APA (7th ed.) Citation

Young Kwon Koh, Su Hyun Yoon, Sung Han Kang, Hyery Kim, Ho Joon Im, Pyeong Hwa Kim, . . . Kyung-Nam Koh. (2022). Improvement of Neurodegenerative Disease after Use of Vemurafenib in Refractory BRAF V600E-Mutated Langerhans Cell Histiocytosis: A Case Report. The Korean Society of Pediatric Hematology-Oncology.

Chicago Style (17th ed.) Citation

Young Kwon Koh, Su Hyun Yoon, Sung Han Kang, Hyery Kim, Ho Joon Im, Pyeong Hwa Kim, Ah Young Jung, and Kyung-Nam Koh. Improvement of Neurodegenerative Disease After Use of Vemurafenib in Refractory BRAF V600E-Mutated Langerhans Cell Histiocytosis: A Case Report. The Korean Society of Pediatric Hematology-Oncology, 2022.

MLA (9th ed.) Citation

Young Kwon Koh, et al. Improvement of Neurodegenerative Disease After Use of Vemurafenib in Refractory BRAF V600E-Mutated Langerhans Cell Histiocytosis: A Case Report. The Korean Society of Pediatric Hematology-Oncology, 2022.